A Novel Drug Modulator Diarylheptanoid (trans-1,7-Diphenyl-5-hydroxy-1-heptene) from Curcuma comosa Rhizomes for P-glycoprotein Function and Apoptosis Induction in K652/ADR Leukemic Cells
Authors:
- Natsima ViriyaadhammaaNVNatsima Viriyaadhammaa
- Suwit DuangmanoSDSuwit Duangmano
- Aroonchai SaiaiASAroonchai Saiai
- Montree TungjaiMTMontree Tungjai
- Pornngarm DejkriengkraikulPornngarm Dejkriengkraikul
- Singkome TimaSingkome Tima
- Sawitree ChiampanichayakulSCSawitree Chiampanichayakul
- Jeffrey KriseJKJeffrey Krise
- Songyot AnuchapreedaSongyot Anuchapreeda
Open Access
- 12 August 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (16) , 8989
Abstract
Curcuma comosa has been used in traditional Thai medicine to treat menstrual cycle-related symptoms in women. This study aims to evaluate the diarylheptanoid drug modulator, trans-1,7-diphenyl-5-hydroxy-1-heptene (DHH), in drug-resistant K562/ADR human leukemic cells. This compound was studied due to its effects on cell cytotoxicity, multidrug resistance (MDR) phenotype, P-glycoprotein (P-gp) expression, and P-gp function. We show that DHH itself is cytotoxic towards K562/ADR cells. However, DHH did not impact P-gp expression. The impact of DHH on the MDR phenotype in the K562/ADR cells was determined by co-treatment of cells with doxorubicin (Dox) and DHH using an MTT assay. The results showed that the DHH changed the MDR phenotype in the K562/ADR cells by decreasing the IC50 of Dox from 51.6 to 18.2 µM. Treating the cells with a nontoxic dose of DHH increased their sensitivity to Dox in P-gp expressing drug-resistant cells. The kinetics of P-gp mediated efflux of pirarubicin (THP) was used to monitor the P-gp function. DHH was shown to suppress THP efflux and resulted in enhanced apoptosis in the K562/ADR cells. These results demonstrate that DHH is a novel drug modulator of P-gp function and induces drug accumulation in the Dox-resistant K562 leukemic cell line.Keywords
Funding Information
- Thailand Research Fund (RSA6280034)
- Royal Golden Jubilee PhD Program of Thailand (PHD/0026/2560)
This publication has 26 references indexed in Scilit:
- Triterpenoids as reversal agents for anticancer drug resistance treatmentDrug Discovery Today, 2014
- Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transportersBiochemical Pharmacology, 2012
- Metformin inhibits P‐glycoprotein expression via the NF‐κB pathway and CRE transcriptional activity through AMPK activationBritish Journal of Pharmacology, 2010
- P-Glycoprotein-Mediated Efflux and Drug Sequestration in Lysosomes Confer Advantages of K562 Multidrug Resistance Sublines to Survive Prolonged Exposure to Cytotoxic AgentsAmerican Journal of Applied Sciences, 2009
- Diarylheptanoids, new phytoestrogens from the rhizomes of Curcuma comosa: Isolation, chemical modification and estrogenic activity evaluationBioorganic & Medicinal Chemistry, 2008
- Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powderBiochemical Pharmacology, 2004
- Strategies for Inhibition of MDR1 Gene ExpressionMolecular Pharmacology, 2004
- Mechanisms of Cancer Drug ResistanceAnnual Review of Medicine, 2002
- Novel Nematocidal Agents from Curcuma comosaJournal of Natural Products, 1994
- Studies on the constituents of the seeds of Alpinia katsumadai Hayata.Chemical and Pharmaceutical Bulletin, 1983